2021 Virtual Best of Breast


 

2021 Update on New Agents for mTNBC: ADCs (Sacituzumab Govitecan, Ladiratuzumab Vedotin), PARPi (Olaparib, Talazoparib), AKTi (Capivasertib/Ipatasertib+Paclitaxel)

320 views
January 21, 2021
1 Comment
Login to view comments. Click here to Login